Reducing the Burden of Malaria in HIV-uninfected Pregnant Women and Infants

PHASE3CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

June 23, 2014

Primary Completion Date

May 14, 2018

Study Completion Date

May 14, 2018

Conditions

Malaria

Interventions

DRUG

Monthly dihydroartemisinin-piperaquine (DP) for adult women during pregnancy

DRUG

3 dose dihydroartemisinin-piperaquine (DP) for adult women during pregnancy

DRUG

3 dose sulfadoxine-pyrimethamine (SP) for adult women during pregnancy

DRUG

Monthly dihydroartemisinin-piperaquine (DP) for infants

DRUG

3-monthly dihydroartemisinin-piperaquine (DP) for infants

Trial Locations (1)

IDRC Research Clinic -Tororo District Hospital, Tororo

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Grant Dorsey, M.D, Ph.D.

OTHER

NCT02163447 - Reducing the Burden of Malaria in HIV-uninfected Pregnant Women and Infants | Biotech Hunter | Biotech Hunter